Nuvig Therapeutics
Rebalancing immune function for autoimmune diseases
Palo Alto, United States · Founded 2022 · $161.0M raised
- Headquarters
- Palo Alto, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- nuvigtx.com
- Total Funding
- $161.0M
- Last Round
- $161.0M Series BDec 2024
- Rounds
- 1
About
Nuvig Therapeutics is a biopharma developing immune modulators for chronic inflammatory and autoimmune diseases. Lead NVG-2089 in Phase 2 for CIDP.
Summary
Nuvig Therapeutics is a Biotech company based in Palo Alto, United States, founded in 2022. It has raised $161.0M in total across 1 round, most recently a $161.0M Series B round in Dec 2024.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...